<p>Mayzent is a medicine used to treat adults with an advanced form of multiple sclerosis (MS) known as secondary progressive MS.</p><p>It is used in patients with active disease, which means that patients still have relapses or signs of inflammation can be seen in scans.</p><p>Mayzent contains the active substance siponimod.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Mayzent is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity.</p> </div>
Therapeutic Area (MeSH)
ATC Code
L04
ATC Item
N/A
Pharmacotherapeutic Group
Selective immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| siponimod fumaric acid | N/A | siponimod fumaric acid |
EMA Name
Mayzent
Medicine Name
Mayzent
Aliases
N/ANo risk management plan link.
